Guillain–Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary
greatly in presentation and severity. Besides weakness and sensory disturbances, patients …

Inflammatory neuropathies are a heterogeneous group of rare diseases of the peripheral
nervous system that include acute and chronic diseases, such as Guillain-Barré syndrome …

Axonal injury is a key determinant of long-term outcomes after traumatic brain injury (TBI) but
has been difficult to measure clinically. Fluid biomarker assays can now sensitively quantify …

Introduction Neurological complications among hospitalized COVID‐19 patients may be
associated with elevated neurodegenerative biomarkers. Methods Among hospitalized …

Valid, responsive blood biomarkers specific to peripheral nerve damage would improve
management of peripheral nervous system (PNS) diseases. Neurofilament light chain (NfL) …

Background and Objectives To study the clinical and laboratory features of antineurofascin-
155 (NF155)–positive autoimmune nodopathy (AN). Methods Patients with anti-NF155 …

Neurofilament proteins have been validated as specific body fluid biomarkers of neuro-
axonal injury. The advent of highly sensitive analytical platforms that enable reliable …

Autoimmune neuropathy associated with antibodies against pan-neurofascin is a new
subtype of nodo-paranodopathy. It is relevant because it is associated with high morbidity …

Background and Objectives To investigate CSF findings in relation to clinical and
electrodiagnostic subtypes, severity, and outcome of Guillain-Barré syndrome (GBS) based …

Background and Objectives The clinical course and outcome of the Guillain-Barré syndrome
(GBS) are diverse and vary among regions. The modified Erasmus GBS Outcome Score …